🇺🇸 FDA
Patent

US 11807661

Antibody fusion protein and related compositions for targeting cancer

granted A61KA61K2039/505A61K47/6817

Quick answer

US patent 11807661 (Antibody fusion protein and related compositions for targeting cancer) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K47/6817, A61K9/0019, A61P